Research progress and future prospects for promoting endothelialization on endovascular stents and preventing restenosis

Journal of Medical and Biological Engineering

Volumn 31, Issue 5, 2011, Pages 307-316

  Luo, Caifeng ^a   Zheng, Yiming ^a   Diao, Ziji ^a   Qiu, Juhui ^a   Wang, Guixue ^a  

^a CHONGQING UNIVERSITY   (China)

Author keywords

Endothelial progenitor cells (EPCs); Endothelialization; Restenosis; Stem cells; Stents

Indexed keywords

CARDIO-VASCULAR DISEASE; CARDIOVASCULAR STENTS; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIALIZATION; ENDOVASCULAR STENTS; FUTURE PROSPECTS; IN-VITRO; INTERVENTIONAL TREATMENT; RESEARCH PROGRESS; RESTENOSIS; SEED CELLS; TREATMENT FAILURE; VASCULAR GRAFTS; VASCULAR STENTS;

CELL PROLIFERATION; GRAFTS; STEM CELLS; STENTS;

DISEASES;

CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENDOTHELIZATION; HISTOGENESIS; HUMAN; IN VITRO STUDY; IN-STENT RESTENOSIS; MESENCHYMAL STEM CELL; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; REVIEW; STENT;

EID: 84864720461     PISSN: 16090985     EISSN: None     Source Type: Journal    
DOI: 10.5405/jmbe.958     Document Type: Review

References (132)

1. H. C. Lowe, D. Burkoff, L. M. Khachigian, B. D. MacNeill, M. Hayase and S. N. Oesterle, "Beyond angioplasty: novel developments in interventional cardiology," Intern. Med. J., 32: 470-474, 2002.
2. B. Tesfamariam, "Local vascular toxicokinetics of stent-based drug delivery," Toxicol. Lett., 168: 93-102, 2007.
3. A. Farb, G. Sangiorgi, A. J. Carter, V. M. Walley, W. D. Edwards, R. S. Schwartz and R. Virmani, "Pathology of acute and chronic coronary stenting in humans," Circulation, 99: 44-52, 1999.
4. K. H. Mak, G. Belli, S. G. Ellis and D. J. Moliterno, "Subacute stent thrombosis: evolving issues and current concepts," J. Am. Coll. Cardiol., 27: 494-503, 1996.
5. N. L. Mills, O. Tura, G. J. Padfield, C. Millar, N. N. Lang, D. Stirling, C. Ludlam, M. L. Turner, G. R. Barclay and D. E. Newby, "Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention," Heart, 95: 2003-2008, 2009.
6. J. N. Wilcox, E. I. Okamoto, K. I. Nakahara and J. Vinten-Johansen, "Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors?" Ann. N. Y. Acad. Sci., 947: 68-90, 2001.
7. M. Shuchman, "Debating the risks of drug-eluting stents," N. Engl. J. Med., 356: 325-328, 2007.
8. G. D. Curfman, S. Morrissey, J. A. Jarcho and J. M. Drazen, "Drug-eluting coronary stents-promise and uncertainty," N. Engl. J. Med., 356: 1059-1060, 2007.
9. M. Shuchman, "Trading restenosis for thrombosis? New questions about drug-eluting stents," N. Engl. J. Med., 355: 1949-1952, 2006.
10. R. G. Hauser and B. J. Maron, "Lessons from the failure and recall of an implantable cardioverter-defibrillator," Circulation, 112: 2040-2042, 2005.
11. C. L. Grines, R. O. Bonow, D. E. Casey Jr, T. J. Gardner, P. B. Lockhart, D. J. Moliterno, P. O'Gara and P. Whitlow, "Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians," Circulation, 115: 813-818, 2007.
12. J. Daemen, P. Wenaweser, K. Tsuchida, L. Abrecht, S. Vaina, C. Morger, N. Kukreja, P. Jüni, G. Sianos, Hellige G, R. T. van Domburg, O. M. Hess, E. Boersma, B. Meier, S. Windecker and P. W. Serruys, "Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study," Lancet, 369: 667-678, 2007.
13. T. Deuse, R. G. Erben, F. Ikeno, B. Behnisch, R. Boeger, A. J. Connolly, H. Reichenspurner, C. Bergow, M. P. Pelletier, R. C. Robbins and S. Schrepfer, "Introducing the first polymer-free leflunomide eluting stent," Atherosclerosis, 200: 126-134, 2008.
14. R. Iijima, J. Mehilli, A. Schomig and A. Kastrati, "Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents," Minerva. Cardioangiol., 54: 539-555, 2006.
15. Y. U. Lee, J. Luo, E. Sprague and H. C. Han, "Comparison of artery organ culture and co-culture models for studying endothelial cell migration and its effect on smooth muscle cell proliferation and migration," Ann. Biomed. Eng., 38: 801-812, 2010.
16. N. Kipshidze, G. Dangas, M. Tsapenko, J. Moses, M. B. Leon, M. Kutryk and P. Serruys, "Role of the endot helium in modulating neointimal formation," J. Am. Colle. Cardi., 44: 733-739, 2004.
17. N. L'Heureux, N. Dusserre, A. Marini, S. Garrido, L. de la Cells and Endothelialization on Stents 313 Fuente and T. McAllister, "Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice," Nat. Clin. Pract. Cardiovasc. Med., 4: 389-395, 2007.
18. M. Avci-Adali, G. Ziemer and H. P. Wendel, "Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization: a review of current strategies," Biotechnol. Adv., 28: 119-129, 2010.
19. P. Zilla, "Endothelialization of vascular grafts," Curr. Opin. Cardiol., 6: 877-886, 1991.
20. M. Avci-Adali, N. Perle, G. Ziemer and H. P. Wendel, "Current concepts and new developments for autologous in vivo endothelialisation of biomaterials for intravascular applications," Eur. Cell. Mater., 21: 157-176, 2011.
21. W. Zhu, Y. Tian, L. F. Zhou, Y. Wang, D. Song, Y. Mao and G. Y. Yang, "Development of a novel endothelial cell-seeded endovascular stent for intracranial aneurysm therapy," J. Biomed. Mater. Res. A, 85: 715-721, 2008.
22. Y. Xia, M. Prawirasatya, B. C. Heng, F. Boey and S. S. Venkatraman, "Seeding density matters: extensive intercellular contact masks the surface dependence of endothelial cell-biomaterial interactions," J. Mater. Sci. Mater. Med., 22: 389-396, 2011.
23. N. Swanson, K. Hogrefe, Q. Javed, N. Malik and A. H. Gershlick, "Vascular endothelial growth factor (VEGF)-eluting stents: in vitro effects on thrombosis, endothelialization and intimal hyperplasia," J. Invasive. Cardiol., 15: 688-692, 2003.
24. D. H. Walter, M. Cejna, L. Diaz-Sandoval, S. Willis, L. Kirkwood, P. W. Stratford, A. B. Tietz, R. Kirchmair, M. Silver, C. Curry, A. Wecker, Y. S. Yoon, R. Heidenreich, A. Hanley, M. Kearney, F. O. Tio, P. Kuenzler, J. M. Isner and D. W. Losordo, "Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis," Circulation, 110: 36-45, 2004.
25. C. Tang, G. Wang, X. Wu, Z. Li, Y. Shen, J. C. Lee and Q. Yu, "The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents," J. Vasc. Surg., 53: 461-471, 2011.
26. G. X. Wang, X. Y. Deng, C. J. Tang, L. S. Liu, L. Xiao, L. H. Xiang, X. J. Quan, A. P. Legrand and R. Guidoin, "The adhesive properties of endothelial cells on endovascular stent coated by substrates of poly-l-lysine and fibronectin," Art. Cells Blood Subst. Biotech., 34: 11-25, 2006.
27. C. J. Tang, G. X. Wang, Y. Cao, X. Wu, X. Xie and L. Xiao, "Adhesion and endothelialization of endothelial cells on the surface of endovascular stents by the novel rotational culture of cells," Appl. Surf. Sci., 255: 315-319, 2008.
28. L. S. Liu, D. H. Wei, C. K. Tang, G. X. Wang, S. C. Zhang, W. D. Yin, Y. Z. Yang, A. P. Legrand and R. Guidoin, "A HUVEC line with a stable expression of the VEGF121 gene to achieve complete endothelialization of blood conduits," Artif. Cells Blood Substit. Immobil. Biotechnol., 35: 319-331, 2007.
29. K. O. Cardinal, G. T. Bonnema, H. Hofer, J. K. Barton and S. K. Williams, "Tissue - engineered vascular grafts as in vitro blood vesselmimics for the evaluation of endothelialization of intravascular devices," Tissue Eng., 12: 3431-3438, 2006.
30. S. Kaushal, G. E. Amiel, K. J. Guleserian, O. M. Shapira, T. Perry, F. W. Sutherland, E. Rabkin, A. M. Moran, F. J. Schoen, A. Atala, S. Soker, J. Bischoff and J. E. J. Mayer, "Functional small - diameter neovessels created using endothelial p rogenitor cells expanded ex vivo," Nat. Med., 7: 1035-1040, 2001.
31. K. Mendelson, E. Aikawa, B. A. Mettler, V. Sales, D. Martin, J. E. Mayer and F. J. Schoen, "Healing and remodeling of bioengineered pulmonary artery patches imp lanted in sheep," Cardiovasc. Pathol., 16: 277-282, 2007.
32. H. E. Achneck, R. M. Jamiolkowski, A. E. Jantzen, J. M. Haseltine, W. O. Lane, J. K. Huang, L. J. Galinat, M. J. Serpe, F. H. Lin, M. Li, A. Parikh, L. Ma, T. Chen, B. Sileshi, C. A. Milano, C. S. Wallace, T. V. Stabler, J. D. Allen, G. A. Truskey and J. H. Lawson, "The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants," Biomaterials, 32: 10-18, 2011.
33. J. Allen, S. Khan, M. C. Serrano and G. Ameer, "Characterization of porcine circulating p rogenitor cells: toward a functional endothelium," Tissue Eng. Part A, 14: 183-194, 2008.
34. C. X. Liu, D. Q. Li, Y. Zhang, H. Jiang, R. Wang and X. P. Wang, "Culture of endothelial progenitor cells from rabbit peripheral blood and HTK gene modification," Basic Clin. Med., 11: 1241-1245, 2007.
35. C. M. Li, Z. G. Wang, Y. Q. Gu, J. D. Dong, R. X. Qiu, C. Bian, X. F. Liu and Z. G. Feng, "Preliminary investigation of seeding mesenchymal stem cells on biodegradable scaffolds for vascular tissue engineering in vitro," Asaio. J., 55: 614-619, 2009.
36. Y. Luan, X. C. Liu, G. W. Zhang, R. F. Shi, X. B. Zhao, C. H. Zhao, T. J. Liu, F. Lü, Q. Yang and G. W. He, "Mid-term effect of stem cells combined with transmyocardial degradable stent on swine model of acute myocardial infarction," Coron. Artery Dis., 21: 233-243, 2010.
37. S. H. Lim, S. W. Cho, J. C. Park, O. Jeon, J. M. Lim, S. S. Kim and B. S. Kim, "Tissue-engineered blood vessels with endothelial nitric oxide synthase activity," J. Biomed. Mater. Res. B Appl. Biomater., 85: 537-546, 2008.
38. Z. Gong and L. E. Niklason, "Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs)," Faseb. J., 22: 1635-1648, 2008.
39. S. Cai, Q. Ma, X. Yu, G. Dang and D. Ma, "Expression of human VEGF (121) cDNA in mouse bone marrow stromal cells," Chin. Med. J. (Engl.), 115: 914-918, 2002.
40. G. W. Zhang, X. C. Liu and L. J. Li, "Mechanisms of the protective effects of BMSCs promoted by TMDR with heparinized bFGF-incorporated stent in pig model of acute myocardial ischemia," J. Cell Mol. Med., 15: 1075-1086, 2010.
41. U. Kunter, S. Rong, Z. Djuric, P. Boor, G. Muller-Newen, D. Yu and J. Floege, "Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis," J. Am. Soc. Nephrol., 17: 2202-2212, 2006.
42. R. H. Lee, M. J. Seo, R. L. Reger, J. L. Spees, A. A. Pulin, S. D. Olson and D. J. Prockop, "Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice," Proc. Natl. Acad. Sci. U. S. A., 103: 17438-17443, 2006.
43. H. M. Lazarus, S. E. Haynesworth, S. L. Gerson, N. S. Rosenthal and A. I. Caplan, "Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use," Bone Marrow Transplant., 16: 557-564, 1995.
44. X. Wu, G. Wang, C. Tang, D. Zhang, Z. Li, D. Du and Z. Zhang, "Mesenchymal stem cell seeding promotes reendothelialization of the endovascular stent," J. Biomed. Mater. Res. A, 98: 442-449, 2011.
45. D. G. Phinney and D. J. Prockop, "Concise review: Mesenchymal stem/ multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-current views," Stem Cells, 25: 2896-2902, 2007.
46. L. A. Ortiz, M. Dutreil, C. Fattman, A. C. Pandey, G. Torres, K. Go and D. G. Phinney, "Interleukin 1 receptor antagonist mediates the anti-inflammatory and antifibrotic effect of mesenchymal stem cells during lung injury," Proc. Natl. Acad. Sci. U. S. A., 104: 11002-11007, 2007.
47. G. Keilhoff, F. Stang, A. Goihl, G. Wolf and H. Fansa, "Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination," Cell. Mol. Neurobiol., 26: 1235-1252, 2006.
48. J. Yamashita, H. Itoh, M. Hirashima, M. Ogawa, S. Nishikawa, T. Yurugi, M. Naito, K. Nakao and S. Nishikawa, "Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors," Nature, 408: 92-96, 2000.
49. M. J. Evans and M. H. Kaufman, "Establishment in culture of 314 J. Med. Biol. Eng., Vol. 31 No. 5 2011 pluripotential cells from mouse embryos," Nature, 292: 154-156, 1981.
50. G. R. Martin, "Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells," Proc. Natl. Acad. Sci. U. S. A., 78: 7634-7638, 1981.
51. M. Sone, H. Itoh, J. Yamashita, T. Yurugi-Kobayashi, Y. Suzuki, Y. Kondo, A. Nonoguchi, N. Sawada, K. Yamahara, K. Miyashita, K. Park, M. Shibuya, S. Nito, S. Nishikawa and K. Nakao, "Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells," Circulation, 107: 2085-2088, 2003.
52. S. Levenberg, J. S. Golub, M. Amit, J. Itskovitz-Eldor and R. Langer, "Endothelial cells derived from human embryonic stem cells," Proc. Natl. Acad. Sci. U. S. A., 99: 4391-4396, 2002.
53. S. Le Ricousse-Roussanne, V. Barateau, J. O. Contreres, B. Boval, L. Kraus-Berthier and G. Tobelem, "Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature," Cardiovasc. Res., 62: 176-184, 2004.
54. L. S. Ferreira, S. Gerecht, H. F. Shieh, N. Watson, M. A. Rupnick, S. M. Dallabrida, G. Vunjak-Novakovic and R. Langer, "Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo," Circ. Res., 101: 286-294, 2007.
55. J. C. Gerlach, M. Lübberstedt, J. Edsbagge, A. Ring, M. Hout, M. Baun, I. Rossberg, F. Knöspel, G. Peters, K. Eckert, A. Wulf-Goldenberg, P. Björquist, H. Stachelscheid, T. Urbaniak, G. Schatten, T. Miki, E. Schmelzer and K. Zeilinger, "Interwoven four-compartment capillary membrane technology for three-dimensional perfusion with decentralized mass exchange to scale up embryonic stem cell culture," Cells Tissues Organs, 192: 39-49, 2010.
56. J. C. Gerlach, M. Hout, J. Edsbagge, P. Björquist, M. Lübberstedt, T. Miki, H. Stachelscheid, E. Schmelzer, G. Schatten and K. Zeilinger, "Dynamic 3D culture promotes spontaneous embryonic stem cell differentiation in vitro," Tissue Eng. Part C Methods, 16: 115-121, 2010.
57. O. Abilez, P. Benharash, M. Mehrotra, E. Miyamoto, A. Gale, J. Picquet, C. Xu and C. Zarins, "A novel culture system shows that stem cells can be grown in 3D and under physiologic pulsatile conditions for tissue engineering of vascular grafts," J. Surg. Res., 132: 170-178, 2006.
58. S. Levenberg, N. F. Huang, E. Lavik, A. B. Rogers, J. Itskovitz-Eldor and R. Langer, "Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds," Proc. Natl. Acad. Sci. U. S. A., 100: 12741-12746, 2003.
59. M. B. Nourse, D. E. Halpin, M. Scatena, D. J. Mortisen, N. L. Tulloch, K. D. Hauch, B. Torok-Storb, B. D. Ratner, L. Pabon and C. E. Murry, "VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering," Arterioscler. Thromb. Vasc. Biol., 30: 80-89, 2010.
60. K. Schenke-Layland, K. E. Rhodes, E. Angelis, Y. Butylkova, S. Heydarkhan-Hagvall, C. Gekas, R. Zhang, J. I. Goldhaber, H. K. Mikkola, K. Plath and W. R. MacLellan, "Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages," Stem Cells, 26: 1537-1546, 2008.
61. L. Kang, J. Wang, Y. Zhang, Z. Kou and S. Gao, "iPSCs can support full-term development of tetraploid blastocyst-complemented embryos," Cell Stem Cell, 5: 135-138, 2009.
62. X. Y. Zhao, W. Li, Z. Lv, L. Liu, M. Tong, T. Hai, J. Hao, C. L. Guo, Q.W. Ma, L. Wang, F. Zeng and Q. Zhou, "iPSCs produce viable mice through tetraploid complementation," Nature, 461: 86-90, 2009.
63. G. Narazaki, H. Uosaki, M. Teranishi, K. Okita, B. Kim, S. Matsuoka, S. Yamanaka and J. K. Yamashita, "Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells," Circulation, 118: 498-506, 2008. [64] C. Q. Xie, H. Huang, S. Wei, L. S. Song, J. Zhang, R. P. Ritchie, L. Chen, M. Zhang and Y. E. Chen, "A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells," Stem Cells Dev., 18: 741-748, 2009.
64. C. Q. Xie, H. Huang, S. Wei, L. S. Song, J. Zhang, R. P. Ritchie, L. Chen, M. Zhang and Y. E. Chen, "A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells," Stem Cells Dev., 18: 741-748, 2009.
65. M. G. Engelmann and W. M. Franz, "Stem cell therapy after myocardial infarction: ready for clinical application?," Curr. Opin. Mol. Ther., 8: 396-414, 2006.
66. J. T. Dimos, K. T. Rodolfa, K. K. Niakan, L. M. Weisenthal, H. Mitsumoto, W. Chung, G. F. Croft, G. Saphier, R. Leibel, R. Goland, H. Wichterle, C. E. Henderson and K. Eggan, "Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons," Science, 321: 1218-1221, 2008.
67. F. Soldner, D. Hockemeyer, C. Beard, Q. Gao, G. W. Bell, E. G. Cook, G. Hargus, A. Blak, O. Cooper, M. Mitalipova, O. Isacson and R. Jaenisch, "Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors," Cell, 36: 964-977, 2009.
68. N. L'Heureux, N. Dusserre, A. Marini, S. Garrido, L. de la Fuente and T. McAllister, "Technology insight: The evolution of tissue-engineered vascular graft sd f rom research to clinical practice," Nat. Clin. Pract. Cardiovasc. Med., 4: 389-395, 2007.
69. F. Quaini, K. Urbanek, A. P. Beltrami, N. Finato, C. A. Beltrami, B. Nadal-Ginard, J. Kajstura and A. Leri, "P. Anversa, Chimerism of the transplanted heart," N. Engl. J. Med., 34: 5-15, 2002.
70. B. T. Suratt, C. D. Cool, A. E. Serls, L. Chen, M. Varella-Garcia, E. J. Shpall, K. K. Brown and G. S. Worthen, "Human pulmonary chimerism after hematopoietic stem cell transplantation," Am. J. Respir. Crit. Care Med., 168: 318-322, 2003.
71. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman and J. M. Isner, "Isolation of putative progenitor endothelial cells for angiogenesis," Science, 275: 964-967, 1997.
72. M. Peichev, A. J. Naiyer, D. Pereira, Z. Zhu, W. J. Lane, M. Williams, M. C. Oz, D. J. Hicklin, L. Witte, M. A. Moore and S. Rafii, "Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors," Blood, 95: 952-958, 2000.
73. U. M. Gehling, S. Ergün, U. Schumacher, C. Wagener, K. Pantel, M. Otte, G. Schuch, P. Schafhausen, T. Mende, N. Kilic, K. Kluge, B. Schäfer, D. K. Hossfeld and W. Fiedler, "In vitro differentiation of endothelial cells from AC 133 positive progenitor cells," Blood, 95: 3106-3112, 2000.
74. A. Casamassimi, M. L. Balestrieri, C. Fiorito, C. Schiano, C. Maione, R. Rossiello, V. Grimaldi, V. Del Giudice, C. Balestrieri, B. Farzati, V. Sica and C. Napoli, "Comparison between total endothelial progenitor cell isolation versus enriched CD133+ culture," J. Biochem., 141: 503-511, 2007.
75. S. Rafii and D. Lyden, "Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration," Nature Medicine, 9: 702-712, 2003.
76. J. Grisar, D. Aletaha, C. W. Steiner, T. Kapral, S. Steiner, D. Seidinger, G. Weigel, I. Schwarzinger, W. Wolozcszuk, G. Steiner and J. S. Smolen, "Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis," Circulation, 111: 204-211, 2005.
77. M. Hristov and C. Weber, "Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance," J. Cell. Mol. Med., 8: 498-508, 2004.
78. A. Zampetaki, J. P. Kirton and Q. Xu, "Vascular repair by endothelial progenitor cells," Cardiovasc. Res., 78: 413-421, 2008.
79. E. Shantsila, T. Watson, H. F. Tse and G. Y. Lip, "New insights on endothelial progenitor cell subpopulations and their angiogenic properties," J. Am. Coll. Cardiol., 51: 669-671, 2008.
80. D. P. Sieveking, A. Buckle, D. S. Celermajer and M. K. Ng, "Strikingly different angiogenic properties of endothelial Cells and Endothelialization on Stents 315 progenitor cell subpopulations: insights from a novel human angiogenesis assay," J. Am. Coll. Cardiol., 51: 660-668, 2008.
81. A. Zampetaki, J. P. Kirton and Q. Xu, "Vascular repair by endothelial progenitor cells," Cardiovasc. Res., 78: 413-421, 2008.
82. G. C. Schatteman, M. Dunnwald and C. Jiao, "Biology of bone marrow-derived endothelial cell precursors," Am. J. Physiol. Heart Circ. Physiol., 292: H1-H18, 2007.
83. D. Kong, L. G. Melo, M. Gnecchi, L. Zhang, G. Mostoslavsky, C. C. Liew, R. E. Pratt and V. J. Dzau, "Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries," Circulation, 110: 2039-2046, 2004.
84. T. Yoshioka, M. Takahashi, Y. Shiba, C. Suzuki, H. Morimoto, A. Izawa, H. Ise and U. Ikeda, "Granulocyte colonystimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice," Cardiovasc. Res., 70: 61-69, 2006.
85. N. Werner, S. Junk, U. Laufs, A. Link, K. Walenta, M. Bohm and G. Nickenig, "Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury," Circ. Res., 93: 17e-24e, 2003.
86. N. Werner, J. Priller, U. Laufs, M. Endres, M. Böhm, U. Dirnagl and G. Nickenig, "Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition," Arterioscler. Thromb. Vasc. Biol., 22: 1567-1572, 2002.
87. T. Takahashi, C. Kalka, H. Masuda, D. Chen, M. Silver, M. Kearney, M. Magner, J. M. Isner and T. Asahara, "Ischemiaand- and cytokine-induced mobilization of bone-marrow-derived endothelial progenitor cells for neovascularization," Nat. Med., 5: 434-438, 1999.
88. C. Kalka, H. Masuda, T. Takahashi, R. Gordon, O. Tepper, E. Gravereaux, A. Pieczek, H. Iwaguro, S. I. Hayashi, J. M. Isner and T. Asahara, "Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects," Circ. Res., 86: 1198-1202, 2000.
89. C. Kalka, H. Tehrani, B. Laudenberg, P. R. Vale, J. M. Isner, T. Asahara and J. F. Symes, "VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease," Ann. Thorac. Surg., 70: 829-834, 2000.
90. M. Gill, S. Dias, K. Hattori, M. L. Rivera, D. Hicklin, L. Witte, L. Girardi, R. Yurt, H. Himel and S. Rafii, "Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells," Circ. Res., 88: 167-174, 2001.
91. T. Asahara, T. Takahashi, H. Masuda, C. Kalka, D. Chen, H. Iwaguro, Y. Inai, M. Silver and J. M. Isner, "VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells," EMBO J., 18: 3964-3972, 1999.
92. A. Kawamoto, H. C. Gwon, H. Iwaguro, J. I. Yamaguchi, S. Uchida, H. Masuda, M. Silver, H. Ma, M. Kearney, J. M. Isner and T. Asahara, "Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia," Circulation, 103: 634-637, 2001.
93. C. Urbich, C. Heeschen, A. Aicher, E. Dernbach, A. M. Zeiher and S. Dimmeler, "Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells," Circulation, 108: 2511-2516, 2003.
94. T. Murohara, "Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors," Trends Cardiovasc. Med., 11: 303-307, 2001.
95. D. H. Walter, K. Rittig, F. H. Bahlmann, R. Kirchmair, M. Silver, T. Murayama, H. Nishimura, D. W. Losordo, T. Asahara and J. M. Isner, "Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells," Circulation, 105: 3017-3024, 2002.
96. K. Strehlow, N. Werner, J. Berweiler, A. Link, U. Dirnagl, J. Priller, K. Laufs, L. Ghaeni, M. Milosevic, M. Böhm and G. Nickenig, "Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation," Circulation, 107: 3059-3065, 2003.
97. T. He, L. A. Smith, S. Harrington, K. A. Nath, N. M. Caplice and Z. S. Katusic, "Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries," Stroke, 35: 2378-2384, 2004.
98. D. P. Griese, A. Ehsan, L. G. Melo, D. Kong, L. Zhang, M. J. Mann, R. E. Pratt, R. C. Mulligan and V. J. Dzau, "Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy," Circulation, 108: 2710-2715, 2003.
99. J. Hur, C. H. Yoon, C. S. Lee, T. Y. Kim, I. Y. Oh, K. W. Park, J. H. Kim, H. S. Lee, H. J. Kang, I. H. Chae, B. H. Oh, Y. B. Park and H. S. Kim, "Akt is a keymodulator of endothelial progenitor cell trafficking in ischemic muscle," Stem Cells, 25: 1769-1778, 2007.
100. K. Stellos and M. Gawaz, "Platelets and stromal cell-derived factor-1 in progenitor cell recruitment," Semin. Thromb. Hemost., 33: 159-164, 2007.
101. Y. G. Yin, X. H. Zhao, Y. Q. Fang, S. Y. Yu, J. H. Zhao, M. B. Song and L. Huang, "SDF-1 alpha involved in mobilization and recruitment of endothelial progenitor cells after arterial injury in mice," Cardiovasc. Pathol., 19: 218-227, 2010.
102. J. Honold, R. Lehmann, C. Heeschen, D. H. Walter, B. Assmus, K. Sasaki, H. Martin, J. Haendeler, A. M. Zeiher and S. Dimmeler, "Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease," Arterioscler. Thromb. Vasc. Biol., 26: 2238-2243, 2006.
103. M. Körbling, J. M. Reuben, H. Gao, B. N. Lee, D. M. Harris, D. Cogdell, S. A. Giralt, I. F. Khouri, R. M. Saliba, R. E. Champlin, W. Zhang and Z. Estrov, "Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis," Transfusion, 46: 1795-1802, 2006.
104. P. H. Huang, Y. H. Chen, C. H. Wang, J. S. Chen, H. Y. Tsai, F. Y. Lin, W. Y. Lo, T. C. Wu, M. Sata, J. W. Chen and S. J. Lin, "Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrowderived endothelial progenitor cells," Arterioscler. Thromb. Vasc. Biol., 29: 1179-1184, 2009.
105. K. Ishizawa, H. Kubo, M. Yamada, S. Kobayashi, T. Suzuki, S. Mizuno, T. Nakamura and H. Sasaki, "Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells," Biochem. Biophys. Res. Commun., 324: 276-280, 2004.
106. C. Heeschen, A. Aicher, R. Lehmann, S. Fichtlscherer, M. Vasa, C. Urbich, C. Mildner-Rihm, H. Martin, A. M. Zeiher and S. Dimmeler, "Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization," Blood, 102: 1340-1346, 2003.
107. W. Shim, A. Mehta, S. Y. Lim, G. Zhang, C. H. Lim, T. Chua and P. Wong, "G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?," Cardiovasc. Res., 89: 20-30, 2011.
108. M. Takamiya, M. Okigaki, D. Jin, S. Takai, Y. Nozawa, Y. Adachi, N. Urao, K. Tateishi, T. Nomura, K. Zen, E. Ashihara, M. Miyazaki, T. Tatsumi, T. Takahashi and H. Matsubara, "Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury," Arterioscler. Thromb. Vasc. Biol., 26: 751-757, 2006.
109. Q. Shi, V. Bhattacharya, M. Hong-De Wu and L. R. Sauvage, "Utilizing granulocyte colony-stimulating factor to enhance vascular graft endothelialization from circulating blood cells," Ann. Vasc. Surg., 16: 314-320, 2002.
110. R. Kopan and M. X. Ilagan, "The canonical Notch signaling pathway: unfolding the activation mechanism," Cell, 137: 216-233, 2009.
111. H. Nakagami, N. Nakagawa, Y. Takeya, K. Kashiwagi, C. Ishida, S. Hayashi, M. Aoki, K. Matsumoto, T. Nakamura, T. Ogihara and R. Morishita, "Model of vasculogenesis from embryonic stem cells for vascular research and regenerative medicine," Hypertension, 48: 112-119, 2006.
112. T. Imanishi, K. Kobayashi, T. Hano and I. Nishio, "Effect of estrogen on differentiation and senescence in endothelial progenitor cells derived from bone marrow in spontaneously hypertensive rats," Hypertens. Res., 28: 763-772, 2005.
113. F. H. Seeger, J. Haendeler, D. H. Walter, U. Rochwalsky, J. Reinhold, C. Urbich, L. Rössig, A. Corbaz, Y. Chvatchko, A. M. Zeiher and S. Dimmeler, "p38 mitogen-activated protein kinase downregulates endothelial progenitor cells," Circulation, 111: 1184-1191, 2005.
114. C. Sun, C. Liang, Y. Ren, Y. Zhen, Z. He, H. Wang, H. Tan, X. Pan and Z. Wu, "Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways," Basic. Res. Cardiol., 104: 42-49, 2009.
115. H. Jiang, C. Liang, X. Liu, Q. Jiang, Z. He, J. Wu, X. Pan, Y. Ren, M. Fan, M. Li and Z. Wu, "Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated protein kinase pathways," Atherosclerosis, 210: 71-77, 2010.
116. S. Kuki, T. Imanishi, K. Kobayashi, Y. Matsuo, M. Obana and T. Akasaka, "Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase," Circ. J., 70: 1076-1081, 2006.
117. J. Aoki, P. W. Serruys, H. van Beusekom, A. T. Ong, E. P. McFadden, G. Sianos, W. J. van der Giessen, E. Regar, P. J. de Feyter, H. R. Davis, S. Rowland and M. J. Kutryk, "Endothelial progenitor cell capture by stents coated with antibody against CD34," J. Am. Colle. Cardi., 45: 1575-1597, 2005.
118. B. D. Markway, O. J. McCarty, U. M. Marzec, D. W. Courtman, S. R. Hanson, M. T. Hinds. "Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody," Tissue Eng. Part C Methods, 14: 97-105, 2008.
119. J. I. Rotmans, J. M. Heyligers, H. J. Verhagen, E. Velema, M. M. Nagtegaal, D. P. de Kleijn, F. G. de Groot, E. S. Stroes and G. Pasterkamp, "In vivo cell seeding with ant-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperp lasia in porcine arteriovenous expanded polytetrafluoroethylene grafts," Circulation, 112: 12-18, 2005.
120. D. Simper, P. G. Stalboerger, C. J. Panetta, S. H. Wang and N. M. Caplice, "Smooth muscle progenitor cells in human blood," Circulation, 106: 1199-1204, 2002.
121. M. Sata, A. Saiura, A. Kunisato, A. Tojo, S. Okada, T. Tokuhisa, H. Hirai, M. Makuuchi, Y. Hirata and R. Nagai, "Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis," Nat. Med., 8: 403-409, 2002.
122. D. Skowasch, A. Jabs, R. Andrié, S. Dinkelbach, B. Lüderitz and G. Bauriedel, "Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis," Cardiovasc. Res., 60: 684-691, 2003. [123] C. Tuerk and L. Gold, "Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase," Science, 249: 505-510, 1990.
123. C. Tuerk and L. Gold, "Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase," Science, 249: 505-510, 1990.
124. R. R. Breaker, "Natural and engineered nucleic acids as tools to explore biology," Nature, 432: 838-845, 2004.
125. L. Cerchia, F. Ducongé, C. Pestourie, J. Boulay, Y. Aissouni, K. Gombert, B. Tavitian, V. de Franciscis and D. Libri, "Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase," PLoS Biol., 3: e123, 2005.
126. K. T. Guo, R. Schafer, A. Paul, A. Gerber, G. Ziemer and H. P. Wendel, "A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers," Stem Cells, 24: 2220-2231, 2006.
127. S. P. Ohuchi, T. Ohtsu and Y. Nakamura, "Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface," Biochimie, 88: 897-904, 2006.
128. P. Mallikaratchy, Z. Tang, S. Kwame, L. Meng, D. Shangguan and W. Tan, "Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells," Mol. Cell Proteomics, 6: 2230-2238, 2007.
129. M. S. Raddatz, A. Dolf, E. Endl, P. Knolle, M. Famulok and G. Mayer, "Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting," Angew. Chem. Int. Ed. Engl., 47: 5190-5193, 2008.
130. J. Hoffmann, A. Paul, M. Harwardt, J. Groll, T. Reeswinkel, D. Klee, M. Moeller, H. Fischer, T. Walker, T. Greiner, G. Ziemer and H. P. Wendel, "Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells," J. Biomed. Mater. Res. A, 84: 614-621, 2008.
131. P. M. Consigny, D. A. Silverberg and N. J. Vitali, "Use of endothelial cells containing superparamagnetic microspheres to improve endothelial cell delivery to arterial surfaces after angioplasty," J. Vasc. Interv. Radiol., 10: 155-163, 1999.
132. S. V. Pislaru, A. Harbuzariu, G. Agarwal, T. Witt, R. Gulati, N. P. Sandhu, C. Mueske, M. Kalra, R. D. Simari and G. S. Sandhu, "Magnetic forces enable rapid endothelialization of synthetic vascular grafts," Circulation, 114: I314-I318, 2006.